Deep Tech Startups

LymphaTouch is a Finnish health technology company that manufactures a medical device combining negative pressure and mechanical vibration for manual therapy applications including edema management, soft tissue mobilization, scar therapy, and pain management.

1 investor

Lync Bio develops fourth-generation SMART ADC (antibody-drug conjugate) technology for oncology, leveraging proprietary dual-target conjugate design and payload engineering to improve tumor coverage, cellular response, and manufacturability.

1 investor

Lyrasense provides a cloud-based geospatial intelligence platform that integrates satellite data analysis, AI-powered processing, and visualization to reduce the time from raw data to actionable insights. The platform serves organizations in energy, mining, telecommunications, and other industries that need to process multi-source Earth observation data without building fragmented tool chains.

1 investor

Lysk is a European defense technology startup building modern software designed for hostile environments, bringing cloud infrastructure practices in security and networking to European armies. It serves military and defense organizations across Europe.

1 investor

Lyterian Therapeutics develops pharmaceutical treatments by leveraging protein homeostatic mechanisms to target genetically-validated disease drivers. The company focuses on transformative medicines for patients across multiple disease areas.

1 investor

Lytrix develops photonics technology for AI infrastructure. The company is currently operating in stealth mode.

1 investor

M2 Foundry is a venture studio that builds, funds, and transitions dual-use technology serving both public and private sectors. It identifies technology solutions for national interest needs and creates startups to develop and commercialize them, focusing on financial system security, supply chain resilience, secure AI systems, and decision-ready information.

1 investor

M20 Genomics develops single-cell and spatial transcriptome sequencing technologies for life science research, drug discovery, and disease diagnosis applications. The company offers proprietary VITA and NATA product lines based on its M20 Seq and M20 Spatial technologies.

1 investor

M31 Capital is an investment firm that uses systematic research across physics, history, macroeconomics, technology, and geopolitics to identify emerging technology paradigm shifts. The firm advises private investors, institutions, and sovereign wealth funds on long-term technology trends and investment positioning.

1 investor

M31 is a product and service development partner that designs and engineers custom hardware and software across sectors including biomedical devices, security and monitoring systems, industrial applications, home/building automation and smart cities, cloud and digital twins, and automotive/racing. It works with client companies to build new products, from diagnostic instruments and connected devices to industrial controllers and edge/cloud systems.

1 investor

M3triq offers computational drug design and discovery, generating proteins and molecules such as antibodies, nanobodies, enzymes, binders, and small molecules and ranking candidates through virtual screening, molecular docking, structure prediction, and ADMET triage. It serves biotech and pharmaceutical teams either as a full service campaign run by its scientists or as self-serve AI agents for in-house design and discovery.

1 investor

M5Stack builds modular, open-source IoT development hardware alongside software tools, serving developers and businesses working on industrial IoT, smart retail, home automation, AI applications, and STEM education. Founded in China in 2017, it offers core controllers, sensor units, and development software with support for connectivity protocols like Wi-Fi, BLE, CAN, and LoRa.

1 investor

MA-TEK manufactures high-technology products and components, offering services in packaging, testing, and systems integration with advanced analytical detection techniques. The company supports research and development in innovative components and materials, primarily serving academic and industrial partners in Taiwan.

1 investor

Maaind builds emotion- and physiological-state detection technology that fuses voice, vision, and cardiac signals to read a person's emotion, stress, focus, fatigue, drowsiness, and engagement in real time. Its inference engine runs in the cloud or on-device offline, serving automotive driver/occupant monitoring, voice AI agents, health and wellbeing, defence operator monitoring, and insurance.

1 investor

Maargin is building a multi-shell, multi-orbit space communication network — a constellation of LEO satellites interconnected via optical inter-satellite links (OISL) — to provide connectivity and in-orbit computing for enterprises, government agencies, aircraft, maritime businesses, other satellites and deep-space missions. The network uses 3GPP-compliant waveforms and is designed to interoperate with existing terrestrial and space systems, with each satellite doubling as a micro data centre node in an orbital compute grid.

1 investor

MabGenesis is a Japanese startup biopharmaceutical company that commercializes decades of academic antibody research to develop first-in-class and best-in-class therapeutic monoclonal antibody drugs for both human and animal use. Using its MOURA antibody library and IMPACT high-efficiency monoclonal antibody isolation technology, it targets high-unmet-need areas such as cancer and zoonotic diseases, and has built dog and cat antibody libraries for the veterinary drug market.

1 investor

MNE is an oil and gas exploration company that develops two exploration permits in Western Australia's Northern Perth Basin. The company focuses on prospecting and development activities in onshore regions of Western Australia.

1 investor

Mach42 develops AI tools for high-performance computing tasks, including analog circuit simulation and test plan development for semiconductors as well as real-time fusion control mechanisms. Its products target chip design and verification workflows, such as accelerated design exploration for silicon verification.

1 investor

MACOM designs and manufactures semiconductor products across silicon, gallium arsenide, and indium phosphide technologies, serving customers who need specialized semiconductor solutions. The company operates fabrication facilities, design centers, and foundry services globally.

1 investor

MacroBreed develops improved kelp varieties using genomic technologies to breed seaweed with better growth, resilience, and nutritional properties. The company works in marine biotechnology and sustainable aquaculture.

1 investor

Macromoltek is a computational drug design company that uses a proprietary platform to produce de novo antibody designs, including against difficult targets not accessible through traditional methods. It serves large biopharmaceutical companies and smaller biotechs.

1 investor

Macrotope engineers protein antigens using its patented MacroAntigen/MAV platform, which tunes antigen conformational dynamics to broaden immune response for vaccine and therapeutic antibody discovery. It develops its own vaccine candidates (including for SARS-CoV-2 and related coronaviruses) and offers antibody discovery services to biopharma partners.

1 investor

MAG-LAB provides NMR spectroscopy services combined with selective protein isotope labeling techniques to analyze protein-ligand interactions at atomic resolution for drug discovery. It supports pharmaceutical and medicinal chemistry teams in hit finding, hit-to-lead optimization, binding site mapping, and characterizing challenging targets including intrinsically disordered proteins.

1 investor

Magma Global manufactures m-pipe, a composite subsea pipeline system made from PEEK and carbon fibre for oil and gas exploration and production. The product replaces traditional steel and flexible pipes in deep-water applications, delivering cost savings up to 65% while reducing corrosion, temperature, and pressure challenges.

1 investor